Value-Based Pricing in Latin America

How Far Away Are We?

ISPOR Health Technology Assessment Latin America Roundtable

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

In February and September of 2017, the International Society for Pharmacoeconomics and Outcomes Research Health Technology Assessment Council held roundtables focused on Latin America to discuss health technology assessment best practices, collaboration opportunities, and regional experiences regarding health policies to improve the affordability of and access to healthcare technologies. The access to high-cost technologies, increased social pressure to achieve universal coverage, population aging, and the limits of traditional mechanisms to control costs create political pressure to begin considering other pricing alternatives, including value-based pricing, in Latin America. This article attempts to conceptualize key stakeholders' perceptions of their experiences, opportunities, and barriers to implementing value-based pricing in Latin America.

Original languageEnglish
JournalValue in Health Regional Issues
Volume17
Pages (from-to)219-223
ISSN2212-1099
DOIs
Publication statusPublished - 2018

Fingerprint

Latin America
pricing
technology assessment
Values
costs
health
health policy
best practice
experience
coverage
stakeholder

Keywords

  • Latin America
  • national health insurance
  • pricing
  • value-based pricing

Cite this

ISPOR Health Technology Assessment Latin America Roundtable. / Value-Based Pricing in Latin America : How Far Away Are We?. In: Value in Health Regional Issues. 2018 ; Vol. 17. pp. 219-223.
@article{4e2fe3294ba648878c8739609c6e7e1d,
title = "Value-Based Pricing in Latin America: How Far Away Are We?",
abstract = "In February and September of 2017, the International Society for Pharmacoeconomics and Outcomes Research Health Technology Assessment Council held roundtables focused on Latin America to discuss health technology assessment best practices, collaboration opportunities, and regional experiences regarding health policies to improve the affordability of and access to healthcare technologies. The access to high-cost technologies, increased social pressure to achieve universal coverage, population aging, and the limits of traditional mechanisms to control costs create political pressure to begin considering other pricing alternatives, including value-based pricing, in Latin America. This article attempts to conceptualize key stakeholders' perceptions of their experiences, opportunities, and barriers to implementing value-based pricing in Latin America.",
keywords = "Latin America, national health insurance, pricing, value-based pricing",
author = "Aurelio Mej{\'i}a and Ramiro Gilardino and Kristensen, {Finn B{\o}rlum} and Garrison, {Louis P.} and {ISPOR Health Technology Assessment Latin America Roundtable}",
year = "2018",
doi = "10.1016/j.vhri.2018.09.007",
language = "English",
volume = "17",
pages = "219--223",
journal = "Value in Health Regional Issues",
issn = "2212-1099",
publisher = "Elsevier",

}

ISPOR Health Technology Assessment Latin America Roundtable 2018, 'Value-Based Pricing in Latin America: How Far Away Are We?', Value in Health Regional Issues, vol. 17, pp. 219-223. https://doi.org/10.1016/j.vhri.2018.09.007

Value-Based Pricing in Latin America : How Far Away Are We? / ISPOR Health Technology Assessment Latin America Roundtable.

In: Value in Health Regional Issues, Vol. 17, 2018, p. 219-223.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Value-Based Pricing in Latin America

T2 - How Far Away Are We?

AU - Mejía, Aurelio

AU - Gilardino, Ramiro

AU - Kristensen, Finn Børlum

AU - Garrison, Louis P.

AU - ISPOR Health Technology Assessment Latin America Roundtable

PY - 2018

Y1 - 2018

N2 - In February and September of 2017, the International Society for Pharmacoeconomics and Outcomes Research Health Technology Assessment Council held roundtables focused on Latin America to discuss health technology assessment best practices, collaboration opportunities, and regional experiences regarding health policies to improve the affordability of and access to healthcare technologies. The access to high-cost technologies, increased social pressure to achieve universal coverage, population aging, and the limits of traditional mechanisms to control costs create political pressure to begin considering other pricing alternatives, including value-based pricing, in Latin America. This article attempts to conceptualize key stakeholders' perceptions of their experiences, opportunities, and barriers to implementing value-based pricing in Latin America.

AB - In February and September of 2017, the International Society for Pharmacoeconomics and Outcomes Research Health Technology Assessment Council held roundtables focused on Latin America to discuss health technology assessment best practices, collaboration opportunities, and regional experiences regarding health policies to improve the affordability of and access to healthcare technologies. The access to high-cost technologies, increased social pressure to achieve universal coverage, population aging, and the limits of traditional mechanisms to control costs create political pressure to begin considering other pricing alternatives, including value-based pricing, in Latin America. This article attempts to conceptualize key stakeholders' perceptions of their experiences, opportunities, and barriers to implementing value-based pricing in Latin America.

KW - Latin America

KW - national health insurance

KW - pricing

KW - value-based pricing

U2 - 10.1016/j.vhri.2018.09.007

DO - 10.1016/j.vhri.2018.09.007

M3 - Journal article

VL - 17

SP - 219

EP - 223

JO - Value in Health Regional Issues

JF - Value in Health Regional Issues

SN - 2212-1099

ER -